Follow the people · Insider
Brooke Story
Brooke Story files insider transactions with the SEC as a director of LivaNova (LIVN). We hold 1 disclosed purchase or sale filed since 16 June 2021, 1 of them in the last 90 days.
- Files forLIVN
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure8 September 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 September 2022 — 4 September 2026Director · LivaNova (LIVN)19 Form 4 lines · source: SEC Form 4
- Filed 15 July 2026 — 15 July 2026Director · PolyPid (PYPD)1 Form 4 line · source: SEC Form 4
- Filed 14 June 2021 — 26 May 2022Director · Sigilon Therapeutics (SGTX)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
22 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 2,300 shares of LivaNovaSEC Form 48 September 2026Ordinary Shares · traded 4 September 2026 · filed 8 September 2026
- was granted 9,132 shares of PolyPid (a derivative holding)SEC Form 417 July 2026Stock option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 4,042 shares of LivaNovaSEC Form 417 June 2026Ordinary Shares · traded 15 June 2026 · filed 17 June 2026
- had shares withheld for tax on 486 shares of LivaNovaSEC Form 417 June 2026Ordinary Shares · traded 15 June 2026 · filed 17 June 2026
- exercised options over 4,042 shares of LivaNova (a derivative holding)SEC Form 417 June 2026Restricted Stock Units · traded 15 June 2026 · filed 17 June 2026
- was granted 2,383 shares of LivaNova (a derivative holding)SEC Form 417 June 2026Restricted Stock Units · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 250 shares of LivaNovaSEC Form 419 November 2025Ordinary Shares · traded 18 November 2025 · filed 19 November 2025
- exercised options over 3,416 shares of LivaNova (a derivative holding)SEC Form 417 June 2025Restricted Stock Units · traded 15 June 2025 · filed 17 June 2025
- was granted 4,042 shares of LivaNova (a derivative holding)SEC Form 417 June 2025Restricted Stock Units · traded 15 June 2025 · filed 17 June 2025
- exercised options over 3,416 shares of LivaNovaSEC Form 417 June 2025Ordinary Shares · traded 15 June 2025 · filed 17 June 2025
- had shares withheld for tax on 410 shares of LivaNovaSEC Form 417 June 2025Ordinary Shares · traded 15 June 2025 · filed 17 June 2025
- exercised options over 2,680 shares of LivaNova (a derivative holding)SEC Form 418 June 2024Restricted Stock Units · traded 15 June 2024 · filed 18 June 2024
- was granted 3,416 shares of LivaNova (a derivative holding)SEC Form 418 June 2024Restricted Stock Units · traded 15 June 2024 · filed 18 June 2024
- exercised options over 2,680 shares of LivaNovaSEC Form 418 June 2024Ordinary Shares · traded 15 June 2024 · filed 18 June 2024
- had shares withheld for tax on 584 shares of LivaNovaSEC Form 418 June 2024Ordinary Shares · traded 15 June 2024 · filed 18 June 2024
- exercised options over 1,725 shares of LivaNova (a derivative holding)SEC Form 419 September 2023Restricted Stock Units · traded 15 September 2023 · filed 19 September 2023
- exercised options over 1,725 shares of LivaNovaSEC Form 419 September 2023Ordinary Shares · traded 15 September 2023 · filed 19 September 2023
- had shares withheld for tax on 345 shares of LivaNovaSEC Form 419 September 2023Ordinary Shares · traded 15 September 2023 · filed 19 September 2023
- was granted 2,680 shares of LivaNova (a derivative holding)SEC Form 420 June 2023Restricted Stock Units · traded 15 June 2023 · filed 20 June 2023
- was granted 1,725 shares of LivaNova (a derivative holding)SEC Form 419 September 2022Restricted Stock Units · traded 15 September 2022 · filed 19 September 2022
- was granted 8,888 shares of Sigilon Therapeutics (a derivative holding)SEC Form 427 May 2022Stock Option (Right to Buy) · traded 26 May 2022 · filed 27 May 2022
- was granted 17,777 shares of Sigilon Therapeutics (a derivative holding)SEC Form 416 June 2021Stock Option (Right to Buy) · traded 14 June 2021 · filed 16 June 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.